GURUFOCUS.COM » STOCK LIST » UK/Ireland » UK » LSE » ValiRx PLC (LSE:VAL) » Definitions » Short Interest
Switch to:

ValiRx (LSE:VAL) Short Interest

View and export this data going back to 2000. Start your Free Trial

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison

For the Biotechnology subindustry, ValiRx's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ValiRx Short Interest Distribution

For the Biotechnology industry and Healthcare sector, ValiRx's Short Interest distribution charts can be found below:

* The bar in red indicates where ValiRx's Short Interest falls in comparison to its industry or sector. The grey bar indicates the Short Interest's extreme value range as defined by GuruFocus.

ValiRx (LSE:VAL) Business Description

ValiRx logo
Traded in Other Exchanges
Chelmsford Road, Stonebridge House, Hatfield Heath, Essex, GBR, CM22 7BD
ValiRx PLC is a UK-based biopharmaceutical company. It mainly engages in developing technologies and products in oncology therapeutics and diagnostics. The area of focus for the company is the treatment of cancer and associated biomarkers, specializing in the epigenomic and genetic analysis. The company develops therapeutics across fields in oncology and has a portfolio of products in the pipeline which include GeneICE for Silencing Rebellious Genes, VAL201 for prostate cancer, NAV3 for the cancer screening test, and VAL401 for lung cancer.

ValiRx (LSE:VAL) Headlines

Other Sources

Valaris Announces New Chief Financial Officer

By Yahoo Finance 2022-08-03

Valaris Reports Third Quarter 2022 Results

By Yahoo Finance 2022-10-31

Valaris Reports Second Quarter 2022 Results

By Yahoo Finance 2022-08-01